Construction and Clinical Application of the Immune Map of Pancreatic Cancer Evolution
Recruiting
Observational Study
Immune Evasion, Tumor
Pancreas Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 80
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,500 (estimated)
- Sponsor
- First Affiliated Hospital of Zhejiang University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The intricate interplay between systemic immunity and tumors profoundly influences not only the onset and progression of tumors but also serves as a crucial window into understanding tumor evolution and treatment status. This project aims to establish a large, multi-center pancreatic cancer cohort and a standardized clinical sample repository, capturing multimodal immunity big data on pancreatic c…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Healthy individuals without benign or malignant liver, gallbladder, and pancreas diseases
* Primary PDAC
* Patients with benign pancreatic tumors
* IPMN patients diagnosed by pathology/imaging
Exclusion Criteria:
* Having autoimmune diseases
* Accompanied by other malignant …
Contacts